Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlong Oral Liquid for Chronic Persistent Asthma
ChiCTR2400081684Phase 4Recruiting
- Sponsor
- Tongde Hospital of Zhejiang Province
- Start
- Mar 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in asthma comparing Danlong Oral Liquid + standard treatment with Placebo + standard treatment (2 arms). Primary endpoints: Asthma Control Test score, Pulmonary function and 3 more. Started Mar 2024; status: recruiting.
02
Drugs
Danlong
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR2400081684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081684.